SCHEMBL22102913

SCHEMBL22102913

Cc1c(Cl)ccc2c1CCC2O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 3/20 0.37
OPRM1 P35372 2/20 0.37
UGT2B17 O75795 2/20 0.36
ALDH1A1 P00352 2/20 0.34
MAP3K14 Q99558 1/20 0.34
POLL Q9UGP5 1/20 0.34
ELAVL1 Q15717 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
POLB P06746 1/20 0.33
KCNH2 Q12809 1/20 0.32
ADRA1A P35348 1/20 0.31
NR4A1 P22736 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11352700 0.81 NOTUM (0.37) OPRL1OPRM1MAP3K14POLLCYP11B1
SCHEMBL8179283 0.81 UGT2B17 (0.42) OPRL1OPRM1UGT2B17MAP3K14POLL
SCHEMBL22102575 0.78 OPRM1 (0.34) OPRL1OPRM1MAP3K14POLLCYP11B1
SCHEMBL22102579 0.78 MAP3K14 (0.34) OPRL1OPRM1MAP3K14POLLCYP11B1
SCHEMBL15287132 0.78 MAP3K14 (0.34) OPRL1OPRM1MAP3K14POLLCYP11B1
SCHEMBL23783063 0.78 UGT2B17 (0.36) OPRL1UGT2B17POLLELAVL1KCNH2
SCHEMBL22103239 0.78 MAP3K14 (0.34) OPRL1OPRM1MAP3K14POLLCYP11B1
SCHEMBL8181590 0.78 UGT2B17 (0.36) OPRL1UGT2B17POLLELAVL1KCNH2
SCHEMBL14345512 0.78 UGT2B17 (0.36) OPRL1UGT2B17POLLELAVL1KCNH2
SCHEMBL29660414 0.78 MAP3K14 (0.34) OPRL1OPRM1MAP3K14POLLCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020119592-A1 NOVEL THREE-RING FUSED STRUCTURE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 信达生物制药(苏州)有限公司 2020-06-18 WO disclosed